Comment
. 2008 Dec 18;359(25):2725-6; author reply 2726.
Cetuximab in head and neck cancer
- PMID: 19102011
Item in Clipboard
Comment
Cetuximab in head and neck cancer
N Engl J Med.
.
No abstract available
Comment on
-
Platinum-based chemotherapy plus cetuximab in head and neck cancer.N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656. N Engl J Med. 2008. PMID: 18784101 Clinical Trial.
Similar articles
-
Cetuximab in head and neck cancer.N Engl J Med. 2008 Dec 18;359(25):2725; author reply 2726. doi: 10.1056/NEJMc082096. N Engl J Med. 2008. PMID: 19092159 No abstract available.
-
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.J Clin Oncol. 2005 Aug 20;23(24):5578-87. doi: 10.1200/JCO.2005.07.120. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009949 Clinical Trial.
-
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.J Clin Oncol. 2006 Jun 20;24(18):2866-72. doi: 10.1200/JCO.2005.04.3547. Epub 2006 May 22. J Clin Oncol. 2006. PMID: 16717293 Clinical Trial.
-
[The present situation of neoadjuvant therapy for head and neck carcinoma].Gan To Kagaku Ryoho. 2007 Oct;34(10):1535-7. Gan To Kagaku Ryoho. 2007. PMID: 17940367 Review. Japanese.
-
[Chemotherapy of head and neck cancer].Gan To Kagaku Ryoho. 1996 Feb;23(3):277-82. Gan To Kagaku Ryoho. 1996. PMID: 8712819 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical